COST-EFFECTIVENESS OF ALGINIC ACID IN COMBINATION WITH PROTON PUMP INHIBITOR FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN SYSTEMIC SCLEROSIS PATIENTS

被引:0
|
作者
Foocharoen, C. [1 ]
Kingkaew, P. [2 ]
Teerawattananon, Y. [2 ]
Mahakkanukrauh, A. [1 ]
Suwannaroj, S. [1 ]
Manasirisuk, W. [1 ]
Chaiyarit, J. [3 ]
Sangchan, A. [4 ]
机构
[1] Khon Kaen Univ, Dept Med, Fac Med, Khon Kaen, Thailand
[2] Minist Publ Hlth, Dept Hlth, Hlth Intervent & Technol Assessment Program HITAP, Nonthaburi, Thailand
[3] Khon Kaen Univ, Dept Stat, Fac Sci, Khon Kaen, Thailand
[4] Khon Kaen Univ, Srinagarind Hosp, Special Med Ctr, Fac Med, Khon Kaen, Thailand
关键词
Gastrointestinal tract; Systemic sclerosis;
D O I
10.1136/annrheumdis-2023-eular.495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0923
引用
收藏
页码:1678 / 1678
页数:1
相关论文
共 50 条
  • [41] Effect of potassium competitive acid blocker compared to proton pump inhibitor in gastroesophageal reflux disease
    Wepee, Roderick, Jr.
    Te, Marilyn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 278 - 278
  • [42] Proton pump inhibitor versus potassium-competitive acid blocker in gastroesophageal reflux disease
    Oshima, Tadayuki
    JGH OPEN, 2024, 8 (06):
  • [43] The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease
    Friedlander, Elizabeth A.
    Pallentino, Julia
    Miller, Sally K.
    VanBeuge, Susan S.
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2010, 22 (12): : 674 - 683
  • [45] PROTON PUMP INHIBITORS IN THE TREATMENT OF ACUTE GASTROESOPHAGEAL REFLUX DISEASE
    WOROBETZ, LJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1993, 7 (05): : 417 - 421
  • [46] Gastric mucosa atrophy decreased the efficacy of proton pump inhibitor treatment on gastroesophageal reflux disease
    Wada, Tsuneya
    Sasaki, Makoto
    Kataoka, Hiromi
    Ogasawara, Naotaka
    Kubota, Eiji
    Mori, Yoshinori
    Shimura, Takaya
    Mizoshita, Tsutomu
    Mizushima, Takashi
    Okamoto, Yasuyuki
    Kamiya, Takeshi
    Joh, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A153 - A153
  • [47] Predictors for the development of hypergastrinemia in the maintenance treatment of gastroesophageal reflux disease using a proton pump inhibitor
    Lee, Kwang Jae
    Jung, Da Hyun
    Kang, Seung Joo
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36
  • [48] Gastroesophageal Reflux Treatment With Proton Pump Inhibitors in Patients With Hypertension
    Sertorio, Jonas T. C.
    Tanus-santos, Jose E.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (02) : 157 - 158
  • [49] Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
    de Sa, Claudia Cristina
    Kishi, Humberto Setsuo
    Silva-Werneck, Ana Luiza
    Pinto de Moraes-Filho, Joaquim Prado
    Eisig, Jaime Natan
    Barbuti, Ricardo Correa
    Hashimoto, Claudio Lyioti
    Navarro-Rodriguez, Tomas
    CLINICS, 2011, 66 (04) : 557 - 561
  • [50] Limited Ability of the Proton-Pump Inhibitor Test to Identify Patients With Gastroesophageal Reflux Disease
    Bytzer, Peter
    Jones, Roger
    Vakil, Nimish
    Junghard, Ola
    Lind, Tore
    Wernersson, Borje
    Dent, John
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (12) : 1360 - 1366